HEALING
FRoM WITHIN

Regenerative Exosome Technology and Therapies Activating the Body’s Innate Ability to HEAL,  CURE and IMPROVE Quality of Life

 

Learn More

 

Regenerative medicine holds the promise of providing disruptive medical therapies to improve quality of life and cure untreatable conditions.

Rion harnesses the regenerative power of exosomes to drive the healing potential within the body. Rion's innovative off-the-shelf biologics platforms reduce manufacturing expense paving the path to cost effective and reproducible regenerative therapies.

 

 

We are a GMP, and R&D Commercialized Regenerative Medicine Company Focused on the Discovery and Production of Low-Cost, Off-the-Shelf Regenerative Technologies, and Therapies.

We are leveraging our Purified Exosome Population (PEP) regenerative platform to establish cell-therapy safety and efficacy in areas of unmet clinical needs, with significant and wide-reaching addressable markets. 

REAdILY-AVAILABLE ProDUCT and ThOSE IN DEvELOPMENT

Rion’s flagship exosome product PEP, stems from a naturally occurring healing signal within the body.

PEP technology powers four advanced (RioPEP, RioGEL, RioDERM, RioCOR) and two emerging (RioMESH and RioGENE) product lines to serve a broad array of medical applications.

Our Advanced Product

Our Emerging Products

 

Order RIO PEP Today for Your Studies